WORLDWIDE OPERATIONS

With executive offices in Edison, New Jersey and European operations headquartered in Dublin, Ireland, Oceana Therapeutics is exceptionally well positioned to actively pursue global opportunities to identify, acquire, and commercialize both approved and late-stage development products, primarily focused on devices, pharmaceuticals, and diagnostics addressing unmet and under-satisfied medical needs in colorectal, gastroenterology and urological diseases.

The Company’s rapidly expanding commercial operations include an international sales and distribution network encompassing the US, Europe, and the rest of the world as show below:  

Direct Sales Countries

• United States
• Europe (except Turkey, Greece and Poland which are distributor countries)
• Scandinavia

Distributor Markets

AFRICA

• Egypt
• South Africa
• Tunisia

ASIA

• Hong Kong
• India
• Japan
• Macau            
• Malaysia
• Singapore
• South Korea
• Taiwan

AUSTRALIA/PACIFIC

• Australia

EUROPE

• Belarus
• Greece
• Poland
• Serbia/Montenegro
• Turkey
• Ukraine

MIDDLE EAST

• Bahrain            
• Israel
• Kuwait            
• Qatar                
• Saudi Arabia     
• United Arab Emirates

NORTH AMERICA

• Canada

SOUTH AMERICA

• Brazil
• Chile